Wenfeng Chen, Li Han, Ning Li, Xuan Liu and Fang Yin*
The recent ongoing outbreak of highly contagious viral disease, COVID-19 due to SARS-CoV-2 has sparked worldwide concern. Originally emerged in December 2019 in Wuhan, Hubei Province, Central China; spread quickly across other areas and caused a major epidemic. In response to this serious situation, the World Health Organization (WHO) declared it a global public health emergency of international concern on 30th January, 2020, putting all health organizations on high alert. In China 84, 287 people infected with nCoV-19, which include 4,642 deaths as on 22nd April 2020. Although in China there has been a decline in the spread of the disease, the virus has spread rapidly to 200 countries around the world resulting in over 30 lakhs confirmed infections and 2.50 lakh deaths, and the trend raising on each passing day. Since there are no clinically approved vaccines or specific therapeutic antivirals available, globally most government authorities implemented some unprecedented measures to combat the nCoV-19 transmission. These include the suspension of public transportation, the closing of public spaces and management of communities, isolation and care for infected and suspected cases, and complete locked down to avoid contacting of residents with others. In this article, we systematically review currently available updated literature regarding nCoV-19 epidemic and clinical characteristics, highlighting the strategies adopted successfully by some countries to control the epidemic, which would help other countries respond to the outbreak.
HTML PDFShare this article